| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
34,783 |
31,121 |
$11.63M |
| 0510 |
|
29,941 |
28,067 |
$2.45M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
403 |
318 |
$78K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,242 |
235 |
$27K |
| 0012A |
|
81 |
81 |
$3K |
| 0011A |
|
100 |
85 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
72 |
24 |
$2K |
| Z7500 |
|
16,245 |
15,484 |
$410.20 |
| 80053 |
Comprehensive metabolic panel |
2,094 |
1,823 |
$400.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,548 |
23,275 |
$246.12 |
| 36415 |
Collection of venous blood by venipuncture |
6,657 |
5,471 |
$172.10 |
| 83721 |
|
1,536 |
1,271 |
$137.90 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,017 |
3,850 |
$135.10 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,494 |
1,270 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,862 |
3,186 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,428 |
3,177 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
14,567 |
7,618 |
$0.00 |
| 90656 |
|
321 |
175 |
$0.00 |
| 85027 |
|
822 |
710 |
$0.00 |
| 82607 |
|
166 |
118 |
$0.00 |
| 90686 |
|
909 |
501 |
$0.00 |
| Z7610 |
|
41 |
29 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
475 |
372 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
275 |
253 |
$0.00 |
| 86481 |
|
13 |
13 |
$0.00 |
| 86803 |
|
14 |
13 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
137 |
$0.00 |
| J3490 |
Unclassified drugs |
122 |
76 |
$0.00 |
| 86706 |
|
25 |
24 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
348 |
328 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
863 |
717 |
$0.00 |
| 82728 |
|
22 |
13 |
$0.00 |
| 87340 |
|
31 |
25 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
83 |
72 |
$0.00 |
| 86592 |
|
201 |
182 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
13 |
$0.00 |
| 88142 |
|
46 |
38 |
$0.00 |
| 87625 |
|
27 |
19 |
$0.00 |
| 90688 |
|
41 |
28 |
$0.00 |
| 82746 |
|
23 |
14 |
$0.00 |
| 0271 |
|
12 |
12 |
$0.00 |
| 90739 |
|
85 |
63 |
$0.00 |
| 81001 |
|
13 |
13 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
27 |
19 |
$0.00 |
| 82043 |
|
16 |
12 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
13 |
$0.00 |
| 86704 |
|
13 |
12 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
14,307 |
7,049 |
$0.00 |
| 82465 |
|
802 |
633 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
595 |
383 |
$0.00 |
| 83718 |
|
884 |
696 |
$0.00 |
| 80076 |
|
151 |
119 |
$0.00 |
| 86708 |
|
27 |
26 |
$0.00 |
| 82570 |
|
16 |
12 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 90658 |
|
21 |
13 |
$0.00 |
| 80061 |
Lipid panel |
182 |
180 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
39 |
29 |
$0.00 |
| 81003 |
|
102 |
98 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
56 |
30 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
275 |
253 |
$0.00 |
| 86480 |
|
49 |
49 |
$0.00 |
| 90715 |
|
70 |
52 |
$0.00 |
| 84466 |
|
113 |
89 |
$0.00 |
| 83540 |
|
116 |
92 |
$0.00 |
| 84450 |
|
28 |
26 |
$0.00 |
| 84460 |
|
65 |
50 |
$0.00 |
| 82947 |
|
12 |
12 |
$0.00 |
| 90750 |
|
44 |
29 |
$0.00 |